Business
Sera Prognostics Announces Conference Call and Webcast of Third Quarter 2021 Financial Results on November 9
SALT LAKE CITY, Oct. 27, 2021 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health
About this update from Sera Prognostics, Inc.
[{"type":"text","content":"SALT LAKE CITY, Oct. 27, 2021 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that it will report third quarter 2021 financial results on Tuesday, November 9, 2021, after the close of the market. The Company will host a corresponding conference call and live webcast to discuss operational highlights, financial results and key topics at 5:00 p.m. Eastern Time. A press release outlining the financial results and highlights will be publicly distributed before the call. \n\n \n \n \n \n \n \n\n \nConference Call Details: \nUS domestic callers: (877) 870-4263International callers: (412) 317-0790\nWebcast Registration Link: https://www.webcaster4.com/Webcast/Page/2809/43385\nLive audio of the webcast will be available online from the Investors page of the Company's website at www.seraprognostics.com. The webcast will be archived on the Investors page and will be available for one year. \nAbout Sera Prognostics, Inc.\nSera Prognostics is a leading health diagnostics company dedicated to improving the lives of women and babies through precision pregnancy care. Sera's mission is to deliver early, pivotal information in pregnancy to physicians, enabling them to improve the health of their patients, resulting in reductions in the costs of healthcare delivery. Sera has a robust pipeline of innovative diagnostic tests focused on the early prediction of preterm birth risk and other complications of pregnancy. Sera's precision medicine PreTRM® test reports to a physician the individualized risk of spontaneous premature delivery in a pregnancy, enabling earlier proactive interventions in women with higher risk. Sera Prognostics is located in Salt Lake City, Utah.\nAbout the PreTRM® Test\nThe PreTRM® test, which is ordered by a medical professional, measures and analyzes proteins in the blood that are highly predictive of preterm birth.\nSera Prognostics, the Sera Prognostics logo, The Pregnancy Company, and PreTRM are trademarks or registered trademarks of Sera Prognostics, Inc in the U.S. and/or other countries.\nSafe Harbor Statement\nThis press release contains \"forward-looking statements\" within the meaning of the Private Securities Litigation Reform Act of 1995, i...